Merrimack Pharmaceuticals, Inc.
ANTI-TNFR2 ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases.

Status:
Application
Type:

Utility

Filling date:

28 Feb 2020

Issue date:

8 Sep 2022